CLINICAL FINDINGS
CLINICAL
FINDINGS
TYVASO May Help You
Do What Matters Most
In a clinical study, people who added TYVASO to their current PAH medicine walked farther, improving their 6MWD* in as soon as 6 weeks.†
*6-minute walk distance (6MWD) is a test to see how far you can walk in 6 minutes.
†In the 12-week clinical study of TYVASO, people taking an oral PAH medicine (bosentan or sildenafil) completed a 6-minute walk test at the beginning and end of the study.
Do More in Your Day
When you add TYVASO to your current treatment, you may be able to do things like:
Continuing the Study
After the 12-week clinical study was over, patients who received TYVASO could continue taking it, and patients who had initially received placebo could start on TYVASO.
Nearly all of the patients who completed the initial study (97%) decided to continue as part of the long-term follow-up study.
Nearly all of the patients who completed the initial study (97%) decided to continue as part of the long-term follow-up study.
During that study, researchers followed patients to understand the dosing and safety of TYVASO. They also observed changes in their 6MWD, their ability to be active, and their rate of survival.
Patients Who Took TYVASO in the Clinical Study and Continued to Be Observed…
It’s important to note that in this study, all of the patients were taking TYVASO, and no comparison was made to people who were not taking TYVASO. So, it’s hard to determine for sure if these results are because of TYVASO.
“Everyone's side effects may be different, so it's important to contact your doctor. I will cough after each session, but it's a minor cough. To manage the cough, I usually will take a drink of water."
– Tracey, Living with PAH and Taking TYVASO DPI
You May Have Side Effects
Talk to your healthcare provider and click below to learn more about potential side effects.
Access and Patient Support
Support is in place to help you throughout your treatment journey.
